Efficacy of Long-term Effect and Repeat Intraarticular Botulinum toxin in Patients with Painful Total Joint Arthroplasty: A Retrospective Study
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 1
Abstract
Objective: Based on recent success of intra-articular (IA) Botulinum neurotoxin type A (BoNT/A; OnabotulinumtoxinA) in patients with osteoarthritis, we examined if repeat IA-BoNT/A is an effective antinociceptive in patients with refractory arthroplasty pain. Methods: 11 patients with refractory chronic arthroplasty joint pain without any evidence of infection or prosthesis loosening were referred by orthopedic surgeons. After discussion of off-label use, each patient underwent IA injection of BoNT/A, repeated based on return of pain on numeric rating scale (NRS) and functional limitation on composite validated scales, Western Ontario McMaster Osteoarthritis index (WOMAC) or Shoulder Pain and Disability (SPADI). Results: 11 patients (10 men, 1 woman) with 14 painful arthroplasty joints (3 bilateral; 12 knee and 2 shoulder) underwent ≥1 IA-BoNT/A injections (8 joints injected once, one joint injected twice only, five joints injected thrice) with doses ranging 100-300 units. Mean age was 68 years (standard deviation, 12) and follow-up ranged 1-28 months. Clinically meaningful reduction of 2-units in pain severity and really meaningful reduction in pain severity (50% reduction) were reported by 6/11 patients (6/13 joints) and 3/11 patients (3/13 joints), respectively, 1 month after the first IA-BoNT/A (100-units each). Significant improvements were noted in composite functional scales (WOMAC/SPADI). Pain relief was sustained at 3-4 month follow-up and was reproducible in those who received repeat injections. No significant adverse events were seen in any patients. Conclusions: A single intra-articular injection of BoNT/A improved pain and function in patients with chronic, refractory painful knee or shoulder arthroplasty, which sustained with repeat injections. Patients, who were refractory to the first injection, did not respond to subsequent injections of higher dose of IA-BoNT/A.
Authors and Affiliations
Jasvinder A. Singh
Keywords
Related Articles
- EP ID EP348511
- DOI 10.9734/BJMMR/2014/4897
- Views 60
- Downloads 0
CDKAL1, KCNQ1, and IGF2BP2 are Identified as Type 2 Diabetes Susceptibility Genes in a Regional Chinese Population
Aims: Diabetes has become a major public health problem in China. Recent advances in genetic studies have identified numerous susceptibility loci for type 2 diabetes (T2D). Current models to detect risk of T2D are largel...
Comparative Effects of Garcinia kola and Coffee Diets on Learning and Memory in Mice
Background: Garcinia kola (bitter kola) is one of the most common masticatories in Nigeria having social and ethnomedicinal applications. G. kola seeds are believed to contain caffeine, one of the major constituent of co...
Prevalence of Tonsillolith on Cone Beam Computed Tomography Images in Patients Attending Shahid Beheshti University of Medical Sciences
Aims: The purpose of the present study was to determine the prevalence and characteristics of tonsilloliths on the CBCT radiographs in the archive of the department of oral and maxillofacial radiology in the Shahid Behes...
Body Mass Index and Blood Pressure Pattern through Menarcheal Age in an Italian Village
Aims: Recent investigations correlated early menarche to cardiovascular risk factors in adulthood, whereas others underlined relationship of menarcheal age to body mass index (BMI) and dysmetabolic conditions. Our aim wa...
Organizational Challenges: A Major Obstacle at End of Life Care in Iran
Aims: End-of-life care is a significant part of nursing practice. The role of organizations at the end of life care cannot be ignored. Organization can act as a facilitator to improve the quality of care and provide a pe...